type-2

Documents about type-2

• Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin#18526ClinicalTrials.gov
• 12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients#18527ClinicalTrials.gov
• Effectiveness of Dapagliflozin for Weight Loss#18536ClinicalTrials.gov
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)#18556ClinicalTrials.gov
• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results#18777ClinicalTrials.gov
• Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone#18801ClinicalTrials.gov
• Effect of Diabetes Self-management Education and Support on Glycemic Control Among Patients With Type 2 Diabetic#18815ClinicalTrials.gov
• Special Survey for Patients With Type 1 or Type 2 Diabetes#18819ClinicalTrials.gov
• Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes#18820ClinicalTrials.gov
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes#28472ClinicalTrials.gov
• Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2#28520ClinicalTrials.gov
• Variation of Genes Controlling Carbohydrate and Lipid Metabolism#28542ClinicalTrials.gov
• A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects#28545ClinicalTrials.gov
• Management of Type 2 Diabetes After Gastric Bypass Surgery#28549ClinicalTrials.gov
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes#28550ClinicalTrials.gov
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes#28552ClinicalTrials.gov
• Effect of Metformin on Exercise-induced Lipolysis#28560ClinicalTrials.gov
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control#28577ClinicalTrials.gov
• The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus#28578ClinicalTrials.gov
• A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)#28580ClinicalTrials.gov
• Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone#28582ClinicalTrials.gov
• A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263#28590ClinicalTrials.gov
• Evaluation of Macular Structural and Functional Function Following Extensive Retinal Laser Therapy in Patients With Proliferative Diabetic Retinopathy#67764ClinicalTrials.gov
• Comparison of NN5401 With Insulin Glargine in Insulin Naive Subjects With Type 2 Diabetes#67787ClinicalTrials.gov
• Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes#67796ClinicalTrials.gov
• Low Dose Fat-Induced Insulin Resistance#67799ClinicalTrials.gov
• Video Training to Reduce Insulin Administration Errors#67800ClinicalTrials.gov
• A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes#67818ClinicalTrials.gov
• Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients#67835ClinicalTrials.gov
• A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic Patients#67837ClinicalTrials.gov
• Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus#67844ClinicalTrials.gov
• A Study of LY2599506 in Patients With Type 2 Diabetes#67848ClinicalTrials.gov
• Lifestyle and Glucose Lowering Medication in T2DM#67849ClinicalTrials.gov
• GLUcose Transport and REnalPROtection in Chronic Kidney Disease#67851ClinicalTrials.gov
• BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes#67852ClinicalTrials.gov
• Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated#67855ClinicalTrials.gov
• Telerehabilitation Intervention to Promote Exercise for Diabetes#121228ClinicalTrials.gov
• Dexcom Continuous Glucose Monitoring in Long-term Care#121240ClinicalTrials.gov
• Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects#121255ClinicalTrials.gov
• A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes#121263ClinicalTrials.gov
• A Drug Interaction Study With Albiglutide and Warfarin#121264ClinicalTrials.gov
• The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly#121266ClinicalTrials.gov
• Add Glucokinase Activator to Target A1c#121271ClinicalTrials.gov
• A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus#121277ClinicalTrials.gov
• A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin#121287ClinicalTrials.gov
• An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)#121292ClinicalTrials.gov
• Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes#121299ClinicalTrials.gov
• Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)#121305ClinicalTrials.gov
• AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus#121315ClinicalTrials.gov
• The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin#121316ClinicalTrials.gov

Related topics